Anteilseigner
Capital Research & Management Co. (World Investors) (12,84 %) The Vanguard Group, Inc. (9,25 %) Fidelity Management & Research Co. LLC (7,81 %) Wellington Management Co. LLP (5,73 %) Baillie Gifford & Co. (5,53 %) BlackRock Fund Advisors (4,80 %) Capital Research & Management Co. (International Investors) (2,85 %) T. Rowe Price Investment Management, Inc. (2,72 %) T. Rowe Price Associates, Inc. (Investment Management) (2,69 %) SSgA Funds Management, Inc. (2,48 %) Capital Research & Management Co. (Global Investors) (2,33 %) JPMorgan Investment Management, Inc. (1,93 %) Norges Bank Investment Management (1,62 %) Geode Capital Management LLC (1,53 %) RTW Investments LP (1,30 %) Avoro Capital Advisor LLC (0,88 %) Pictet Asset Management SA (0,70 %) Bellevue Asset Management AG (0,70 %) BlackRock Investment Management (UK) Ltd. (0,64 %)
Kontakt
Alnylam Pharmaceuticals Inc.
3rd Floor, Third Street 300
02142 Cambridge, MA